The financial burden of Chronic Obstructive Pulmonary Disease is too high. Patients have a 30-day readmission rate of 24%.

Our solution is the world's first wearable multimodal physiological sensing system. Our technology addresses the data gap to reduce hospitalization cost and readmission rates.

Our wearable solution creates a portfolio of physiological parameters that allow for a comprehensive cardiopulmonary assessment to be used for early symptom identification and treatment.